Seek and Ye Shall Find: Subclonal Anaplastic Lymphoma Kinase Mutations

Rani E George1

  • 1Department of Pediatric Hematology and Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts. rani_george@dfci.harvard.edu.

Insights

Next-generation sequencing can find hidden anaplastic lymphoma kinase (ALK) mutations in neuroblastoma. This deep sequencing approach may help identify patients eligible for ALK inhibitor therapies.

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • Neuroblastoma is a pediatric cancer characterized by genetic heterogeneity.
  • Anaplastic lymphoma kinase (ALK) mutations are implicated in neuroblastoma development and progression.
  • Targeted therapies for neuroblastoma are under development, necessitating precise patient stratification.

Purpose of the Study:

  • To highlight the utility of next-generation sequencing (NGS) in detecting subclonal anaplastic lymphoma kinase (ALK) mutations in neuroblastoma.
  • To explore the potential of deep sequencing for identifying patients who may benefit from ALK inhibitors.

Main Methods:

  • Utilized next-generation sequencing (deep sequencing) to analyze tumor samples.
  • Focused on the detection of subclonal mutations within the anaplastic lymphoma kinase (ALK) gene.

Main Results:

  • Successfully uncovered subclonal anaplastic lymphoma kinase (ALK) mutations using deep sequencing.
  • Demonstrated the capability of NGS to identify genetic aberrations previously missed by other methods.

Conclusions:

  • Next-generation sequencing is crucial for a comprehensive understanding of neuroblastoma's genetic landscape.
  • Deep sequencing holds promise for identifying patients with actionable ALK mutations for targeted therapy.

Related Concept Videos

Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
15.5K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
10.1K